Glossary
Drug rebate
A payment from a drug maker back to a benefit manager or plan after a sale, tied to formulary placement or volume, which lowers the plan's net cost.
Also called: manufacturer rebate, PBM rebate, formulary rebate
A drug rebate is money a manufacturer pays back to a pharmacy benefit manager or plan after drugs are dispensed. Makers offer rebates in exchange for favorable placement on the formulary, such as a lower tier or fewer restrictions, or for sales volume. The rebate lowers what the plan finally pays, but it is invisible at the pharmacy counter.
As a labeled hypothetical, say a drug has a list price of $500 and the manufacturer pays a $150 rebate. The plan's net cost is $500 - $150 = $350. If your plan charges 20% coinsurance on the list price at the counter, you pay $100, even though the plan's net cost is $350. Some plans base cost sharing on a price after rebates, or pass rebates on to members, but many do not, so check your plan.
Supporters say rebates are how benefit managers win lower prices. Critics say high list prices and large rebates go together, and that patients paying a percentage of list price do not see the benefit. Rules on whether rebates must be shared or disclosed are changing at the state and federal level.
The common mistake is assuming a drug's counter price reflects what the plan pays. It usually does not.
Last reviewed November 16, 2026